Event Details

23rd EURETINA Congress

Oct 5 - Oct 8, 2023

Friday, Oct. 6th, 12:42-12:47pm CET 

A 12-week Phase 2/3 Double-masked, Randomized, Multicenter Study of OCS-01 OPTIREACH® Technology Topical Dexamethasone Eye Drops in Subjects with Diabetic Macular Edema (DME): Efficacy and Safety Findings.

Presented by Prof. Ramin Tadayoni, M.D.

Presented in Euretina Session 6: Landmarks & Late Breakings held from 12:15 to 13:15pm CET